Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

SP100 Protein (AA 116-333) (His tag)

This Recombinant SP100 protein is expressed in Escherichia coli (E. coli).
Catalog No. ABIN7416037

Quick Overview for SP100 Protein (AA 116-333) (His tag) (ABIN7416037)

Target

See all SP100 Proteins
SP100 (SP100 Nuclear Antigen (SP100))

Protein Type

Recombinant

Origin

  • 4
  • 4
  • 1
Rat

Source

  • 4
  • 2
  • 1
  • 1
  • 1
Escherichia coli (E. coli)

Application

Western Blotting (WB), SDS-PAGE (SDS), Immunogen (Imm), Positive Control (PC)

Purity

> 95 %
  • Protein Characteristics

    AA 116-333

    Purification tag / Conjugate

    This SP100 protein is labelled with His tag.

    Sequence

    Phe116-Pro333 (Accession # Q5XI80)

    Characteristics

    Recombinant Sp100 Nuclear Antigen (Sp100), Prokaryotic expression, Phe116-Pro333 (Accession # Q5XI80), N-terminal His Tag
  • Want other Options for this Protein ?

    !
    Discover Our Predefined Custom Proteins and Custom Protein Services!

    Your project requires further customization? Contact us and discover our custom protein solutions

  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Comment

    Isoelectric Point:5.8

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Buffer

    PBS, pH 7.4, containing 0.01 % SKL, 1 mM DTT, 5 % Trehalose and Proclin300.

    Preservative

    ProClin

    Precaution of Use

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C,-80 °C

    Storage Comment

    Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

    Expiry Date

    12 months
  • Target

    SP100 (SP100 Nuclear Antigen (SP100))

    Alternative Name

    Sp100 Nuclear Antigen

    Background

    Speckled 100 kDa, Nuclear dot-associated Sp100 protein

    UniProt

    Q5XI80

    Pathways

    Retinoic Acid Receptor Signaling Pathway
You are here:
Chat with us!